Thermo Fisher Scientific Inc. is a provider of scientific instruments, reagents, consumables, and pharmaceutical services. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. Its portfolio includes biosciences, genetic sciences, bioproduction, chromatography and mass spectrometry, chemical analysis, electron microscopy, clinical diagnostics, immunodiagnostics, microbiology, transplant diagnostics, laboratory products, and clinical research services. Thermo Fisher serves customers in pharmaceutical, biotechnology, academic, government, healthcare, environmental, and industrial markets globally. Key brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, PPD, and Gibco. The company provides outsourced services for drug development, clinical trials, and commercial drug manufacturing, as well as diagnostic test kits and analytical instrumentation for research and clinical applications.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Medical Instruments & Supplies Homepage thermofisher.com
Sector Healthcare IR page ir.thermofisher.com/investors/overview/default.aspx
Tags
life sciences, analytical instruments, diagnostics, biopharma services, genomics, mass spectrometry, chromatography, clinical research, drug discovery, cell culture, protein biology, microbiology, Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, PPD, Gibco
Press page ir.thermofisher.com/investors/news-events/news/default.aspx

Metrics

Valuation  
Market cap $ 259.887B
Market cap (USD) $ 259.887B
P/E 36.99
PEG —
P/BV 4.75
P/S 5.49
P/OCF 27.87
P/FCF 34.21
Dividend yield 0.26%
Turnover / mcap —
Returns  
ROE 13.0%
ROI 7.0%
ROIC 7.5%
Profit margin 15.0%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -1.2%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) No
Debt/Equity 79.2%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 43
Quality score 21.1%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998
Revenue 44.556B 42.879B 42.857B 44.915B 39.211B 32.218B 25.542B 24.358B 20.918B 18.274B 16.965B 16.89B 13.09B 12.51B 11.726B 10.789B 10.11B — — 3.792B 2.633B 2.206B — — — 120.256M — —
Net profit 6.704B 6.338B 5.955B 6.96B 7.728B 6.375B 3.696B 2.938B 2.225B 2.022B 1.975B 1.894B 1.273B 1.178B 1.33B 1.036B 850.3M 994.2M 761.1M 168.935M 223.218M 361.837M 200.009M 309.73M -781K -36.111M -174.573M -174.573M
Free cash flow 6.293B 7.267B 6.927B 6.911B 6.789B 6.815B 4.047B 3.785B 3.497B 2.712B 2.394B 2.192B 1.728B 1.724B 1.425B 1.232B 1.452B 1.156B 1.308B 328.857M 227.368M 214.525M 170.583M 51.68M 103.602M 125.882M 275.883M —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998
Share price 579.45 520.23 530.79 550.69 667.24 465.78 324.87 223.79 189.88 141.1 141.85 125.29 111.35 63.78 44.97 55.36 47.69 34.07 59.25 45.21 — — — — — — — —
Price performance 12m 0.11 -0.02 -0.04 -0.17 0.43 0.43 0.45 0.18 0.35 -0.01 0.13 0.13 0.75 0.42 -0.19 0.16 0.4 -0.42 0.31 — — — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 3.05B 3.88B 4.14B 4.35B 5.74B 7.98B 8.12B 8.22B 8.19B 8.9B
↳ YoY growth +19.8% +27.2% +6.6% +5.1% +32.0% +38.9% +1.7% +1.3% -0.4% +8.7%
↳ 5y CAGR +10.9% +16.5% +16.3% +11.9% +17.7% +21.2% +15.9% +14.7% +13.5% +9.2%
Borrowings, current (USD) 953M 960M 693M 676M 2.63B 2.54B 5.58B 3.61B 2.21B 3.53B
Borrowings, non-current (USD) 15.4B 18.9B 17.7B 17.1B 19.1B 32.3B 28.9B 31.3B 29.1B 35.9B
Lease liabilities (USD) — — — 738M 810M 1.47B 1.59B 1.51B 1.5B 1.47B
Cash and deposits (USD) 786M 1.34B 2.1B 2.4B 10.3B 4.48B 8.52B 8.08B 4.01B 9.85B
Intangible assets (USD) 14B 16.7B 15B 14B 12.7B 20.1B 17.4B 16.7B 15.5B 15.8B
Right-of-use assets (USD) — — — 699M 775M 1.53B 1.59B 1.56B 1.49B 1.45B
Net debt (borrowings + leases - cash) (USD) 15.5B 18.5B 16.3B 16.1B 12.2B 31.9B 27.5B 28.3B 28.8B 31B
Cash flow detail
Operating cash flow (USD) 3.16B 4.01B 4.54B 4.97B 8.29B 9.31B 9.15B 8.41B 8.67B 7.82B
Purchases of property, plant and equipment (USD) -444M -508M -758M -926M -1.47B -2.52B -2.24B -1.48B -1.4B -1.53B
Change in receivables (cash effect) (USD) -352M -362M -366M -225M -1.3B -204M -430M -43M -171M -426M
Change in inventories (cash effect) (USD) 97.8M -81M -324M -458M -508M -1.07B -825M 598M -27M -74M
Change in payables (cash effect) (USD) 55.5M 274M 201M 266M 59M 479M 648M -500M 212M 421M
Dividends paid (cash effect) (USD) -238M -237M -266M -297M -337M -395M -455M -523M -583M -636M
Share buybacks (cash effect) (USD) -1.25B -750M -500M -1.5B -1.5B -2B -3B -3B -4B -3B
Interest paid (cash effect) (USD) -458M -533M -687M -790M -471M -555M -667M -1.39B -1.57B -1.61B
Income taxes paid (cash effect) (USD) -663M -479M -591M -896M -1.32B -2.18B -1.23B -1.48B -1.83B -1.78B
Share-based compensation (USD) 134M 159M 181M 181M 196M 230M 307M 278M 301M 310M
Operating cash flow before change in receivables (USD) 3.51B 4.37B 4.91B 5.2B 9.59B 9.52B 9.58B 8.45B 8.84B 8.24B
Free cash flow (OCF - PPE - intangibles) (USD) 2.71B 3.5B 3.79B 4.05B 6.82B 6.79B 6.91B 6.93B 7.27B 6.29B
Income detail
Research and development expense (USD) 755M 888M 967M 1B 1.18B 1.41B 1.47B 1.34B 1.39B 1.4B
↳ 5y CAGR +17.3% +18.7% +19.6% +7.7% +11.3% +13.2% +10.6% +6.7% +6.7% +3.4%
Total comprehensive income (USD) 1.38B 2.86B 2.53B 3.52B 6.25B 8.21B 6.18B 5.82B 6.86B 6.97B
Comprehensive income to owners (USD) 1.38B 2.86B 2.53B 3.52B 6.25B 8.2B 6.18B 5.87B 6.86B 6.95B
Provision for credit losses (USD) 15.9M 32M 18M 20M 63M — — — — —
Credit cost ratio (credit losses / average receivables) (%) 0.6% 0.9% 0.4% 0.5% 1.2% — — — — —
Reported Feb 28, 2017 Feb 28, 2018 Feb 27, 2019 Feb 26, 2020 Feb 25, 2021 Feb 24, 2022 Feb 23, 2023 Feb 22, 2024 Feb 20, 2025 Feb 26, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Email Alert Sign Up Confirmation Bull 0 Bear 0 Capital return

News Details

Email [](javascript: print()) Twitter Facebook LinkedIn


View all news

Thermo Fisher Scientific Announces Quarterly Dividend

11/05/2026

Download this Press Release(opens in new window)

WALTHAM, Mass.--(BUSINESS WIRE)-- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on January 15, 2027, to shareholders of record as of December 15, 2026.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com .

View source version on businesswire.com: https://www.businesswire.com/news/home/20261105855479/en/

Media Contact Information:
Sandy Pound
Phone: 781-622-1223
E-mail: [email protected]

Website: www.thermofisher.com

Investor Contact Information:
Rafael Tejada
Phone: 781-622-1356
E-mail: [email protected]

Source: Thermo Fisher Scientific Inc.

View all news

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com . 

Company

Brands

Connect

© Copyright 2026 Thermo Fisher Scientific Inc. All rights reserved

Logo for Thermo Fisher ScientificLink to company website

Powered By Q4 Inc. 5.191.0.1 (opens in new window)

Copy link

✓

Thanks for sharing!

Find any service

AddToAny

More…

11/05/2026

Download this Press Release(opens in new window)

New SYBR Green and Probe master mixes have broad compatibility across the instruments, assays and workflows researchers already use

WALTHAM, Mass.--(BUSINESS WIRE)-- Thermo Fisher Scientific, the world leader in serving science, today introduces the Thermo Scientific AmpSure Universal SYBR Green and Probe Master Mixes. Designed for everyday applications, the mixes support reliable, reproducible quantitative PCR (qPCR) performance and offer researchers a value-priced option as labs balance performance with budget.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105419100/en/

Thermo Scientific AmpSure Universal SYBR Green and Probe qPCR Master Mixes

Thermo Scientific AmpSure Universal SYBR Green and Probe qPCR Master Mixes

Consistent performance is essential for generating quality data, completing experiments and publishing research. The AmpSure family includes two master mixes, so researchers can choose the detection chemistry that fits their experiment for a broad range of qPCR applications. AmpSure SYBR Green mix supports routine gene expression analysis, while AmpSure Probe supports multiplexing and applications including gene expression analysis, genotyping and microbe detection.

Both mixes are compatible with leading qPCR instruments and a wide range of reverse transcriptases, and primers and probes. This flexibility allows researchers to use AmpSure with their existing instruments and established workflows.

“Academic, government and small biotech researchers need master mixes they can rely on for everyday qPCR, with the flexibility to work across the instruments and assays already in their labs,” said Ferrier Le, Senior Manager, R&D, Thermo Fisher Scientific. “AmpSure combines reliable performance and value, helping labs make the most of their research budgets and keep research moving forward without changing their existing workflows.”

Unlike many master mixes optimized for specific instruments or workflows, the AmpSure family is designed for broad compatibility. With SYBR Green and Probe master mixes available at the same price per reaction, labs can choose the detection chemistry that fits their experiment and run it across the systems and assays they already use, keeping reagent costs manageable without compromising performance.

To learn more about AmpSure Universal qPCR Master Mixes, please visit thermofisher.com/ampsure .

For Research Use only. Not for use in diagnostic procedures. Pricing and availability are subject to change.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com .

View source version on businesswire.com: https://www.businesswire.com/news/home/20261105419100/en/

Media:
Tiffany Keenan, Greenough Communications
[email protected]

Source: Thermo Fisher

View all news

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com . 

Company

Brands

Connect

© Copyright 2026 Thermo Fisher Scientific Inc. All rights reserved

Logo for Thermo Fisher ScientificLink to company website

Powered By Q4 Inc. 5.191.0.1 (opens in new window)

Copy link

✓

Thanks for sharing!

Find any service

AddToAny

More…

Media Gallery

Newsroom Alerts

To opt-in for email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Thermo Fisher Scientific, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the email alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Thermo Fisher Scientific to send you the requested Email Alert updates.

* Required

Email Address * Email Alert Options *News

Unsubscribe

Email Alert Sign Up Confirmation

Selecting the value will change the page content

Filter by

Items per page: 8 12 16 24

View Science

Download Science

Science

View TFS HQ Drone

Download TFS HQ Drone

TFS HQ Drone

View Logos

Download Logos

Logos

View Company

Download Company

Company

View Science

Download Science

Science

View Science

Download Science

Science

View Company

Download Company

Company

View Science

Download Science

Science

View Product

Download Product

Product

View Science

Download Science

Science

View Company

Download Company

Company

View Company

Download Company

Company

View Company

Download Company

Company

View Science

Download Science

Science

View Science

Download Science

Science

View Science

Download Science

Science

View Science

Download Science

Science

View Product

Download Product

Product

View Science

Download Science

Science

View Product

Download Product

Product

View Science

Download Science

Science

View Product

Download Product

Product

View Product

Download Product

Product

View Science

Download Science

Science

View Science

Download Science

Science

View Product

Download Product

Product

View Product

Download Product

Product

View Science

Download Science

Science

View Science

Download Science

Science

View Science

Download Science

Science

View Product

Download Product

Product

View Science

Download Science

Science

View Product

Download Product

Product

View Science

Download Science

Science

View Science

Download Science

Science

View Product

Download Product

Product

View Science

Download Science

Science

View Science

Download Science

Science

View Science

Download Science

Science

View Product

Download Product

Product

View Product

Download Product

Product

View Product

Download Product

Product

View Science

Download Science

Science

View Science

Download Science

Science

View Product

Download Product

Product

View Product

Download Product

Product

View Science

Download Science

Science

View Product

Download Product

Product

View Product

Download Product

Product

View Product

Download Product

Product

View Product

Download Product

Product

View Product

Download Product

Product

View Product

Download Product

Product

View Product

Download Product

Product

View Product

Download Product

Product

Showing page 1 of 4

  • 1
  • 2
  • 3
  • 4

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com . 

Company

Brands

Connect

© Copyright 2026 Thermo Fisher Scientific Inc. All rights reserved

Logo for Thermo Fisher ScientificLink to company website

Powered By Q4 Inc. 5.191.0.1 (opens in new window)

Prompts

Thermo Fisher Scientific Inc (ticker TMO), listed in United States.

Company History

Date Change Detail
Aug 4, 2016 Acquired Acquired Fei Co (CIK 914329). Its filings from before the deal are on its own company page, not shown here.
Feb 18, 2016 Acquired Acquired Affymetrix Inc (CIK 913077). Its filings from before the deal are on its own company page, not shown here.
Nov 5, 2013 Acquired Acquired Life Technologies Corp (CIK 1073431). Its filings from before the deal are on its own company page, not shown here.
May 14, 2012 Acquired Acquired Princeton Security Technologies, Inc. (CIK 1391614). Its filings from before the deal are on its own company page, not shown here.
Nov 14, 2006 Renamed THERMO ELECTRON CORP → THERMO FISHER SCIENTIFIC INC.
Oct 24, 2006 Acquired Acquired Fisher Scientific International Inc (CIK 880430). Its filings from before the deal are on its own company page, not shown here.

ETFs Holding Thermo Fisher Scientific Inc

ETF Weight in ETF Shares Market value As of
HRTS 5.12% 4,616 $ 2.849M Aug 31, 2026
BEEZ 4.93% 438 $ 300K Nov 18, 2026
CWS 4.91% 7,922 $ 5.441M Nov 17, 2026
BMED 4.35% 902 $ 623.58K Nov 16, 2026
JDOC 4.32% 622 $ 427.183K Nov 17, 2026
PRVS 4.27% 1,736 $ 1.172M Sep 30, 2026
QLTY 4.13% 346,497 $ 213.823M Aug 31, 2026
TMED 4.11% 1,890 $ 947.57K Jun 30, 2026
FMCX 4.07% 7,869 $ 4.856M Aug 31, 2026
FMCE 4.07% 4,578 $ 2.825M Aug 31, 2026
FMED 3.83% 3,200 $ 1.975M Aug 31, 2026
GDOC 3.51% 1,114 $ 687.449K Aug 31, 2026
TOLL 3.17% 3,014 $ 1.86M Aug 31, 2026
QIDX 2.79% 1,886 $ 1.083M Jul 31, 2026
PVAL 2.49% 567,601 $ 350.267M Aug 31, 2026
BEEX 2.45% 6,625 $ 4.58M Nov 17, 2026
KAT 2.26% 29,394 $ 14.737M Jun 30, 2026
JHAC 2.21% 156 $ 78.212K Jun 30, 2026
BKDV 2.08% 66,570 $ 38.231M Jul 31, 2026
HGRO 2.04% 4,490 $ 2.579M Jul 31, 2026
NPFE 2.03% 22,941 $ 13.175M Jul 31, 2026
BLCV 1.94% 10,094 $ 6.978M Nov 16, 2026
THMZ 1.89% 2,044 $ 1.025M Jun 30, 2026
LRGE 1.66% 14,499 $ 7.269M Jun 30, 2026
PINK 1.66% 8,068 $ 5.541M Nov 17, 2026
ROPE 1.56% 561 $ 390K Nov 18, 2026
AQEC 1.54% 17,612 $ 8.83M Jun 30, 2026
RILA 1.52% 1,115 $ 640.345K Jul 31, 2026
MFSG 1.47% 9,063 $ 5.593M Aug 31, 2026
LRGC 1.46% 31,802 $ 19.625M Aug 31, 2026
LCAP 1.43% 52,103 $ 26.122M Jun 30, 2026
RFFC 1.32% 695 $ 428.885K Aug 31, 2026
ALRG 1.30% 189 $ 108.543K Jul 31, 2026
FFND 1.25% 2,005 $ 1.237M Aug 31, 2026
BCGD 1.25% 244 $ 122.332K Jun 30, 2026
BGRO 1.25% 158 $ 109.23K Nov 16, 2026
BDYN 1.23% 53,662 $ 37.098M Nov 16, 2026
WTV 1.16% 68,185 $ 34.185M Jun 30, 2026
JPEF 1.15% 32,332 $ 22.205M Nov 17, 2026
FBCV 1.14% 3,499 $ 2.009M Jul 31, 2026
FPAG 1.11% 11,955 $ 5.994M Jun 30, 2026
WBIF 1.11% 519 $ 260.206K Jun 30, 2026
FRIZ 1.06% 111 $ 55.651K Jun 30, 2026
DFLV 1.02% 112,504 $ 78.69M Nov 12, 2026
SURE 1.02% 849 $ 583.085K Nov 17, 2026
TAX 0.98% 404 $ 249.308K Aug 31, 2026
ZECP 0.98% 5,961 $ 3.679M Aug 31, 2026
LCDS 0.97% 225 $ 154.528K Nov 17, 2026
JOYT 0.94% 1,630 $ 1.119M Nov 17, 2026
DFUV 0.92% 206,205 $ 144.228M Nov 12, 2026
OEI 0.89% 716 $ 411.199K Jul 31, 2026
CAPE 0.87% 4,121 $ 2.066M Jun 30, 2026
MKTN short -0.85% -1,804 $ -904.453K Jun 30, 2026
TVAL 0.84% 13,813 $ 9.549M Nov 17, 2026
MFUT 0.83% 893 $ 617.358K Nov 17, 2026
FFLC 0.81% 16,994 $ 9.76M Jul 31, 2026
WBIG 0.81% 443 $ 222.102K Jun 30, 2026
TCAL 0.76% 3,650 $ 2.523M Nov 17, 2026
HELX 0.76% 421 $ 211.073K Jun 30, 2026
JAVA 0.75% 81,365 $ 55.881M Nov 17, 2026
SROI 0.75% 244 $ 140.129K Jul 31, 2026
CGVV 0.74% 2,162 $ 1.495M Nov 16, 2026
FWD 0.74% 38,305 $ 23.638M Aug 31, 2026
ACLC 0.73% 3,840 $ 2.37M Aug 31, 2026
CGCV 0.71% 25,237 $ 17.447M Nov 16, 2026
WINN 0.70% 12,264 $ 8.587M Nov 13, 2026
DYNF 0.67% 402,626 $ 278.347M Nov 16, 2026
TGRT 0.65% 15,156 $ 10.478M Nov 17, 2026
CGGR 0.65% 236,318 $ 163.374M Nov 16, 2026
ACIO 0.65% 26,455 $ 15.193M Jul 31, 2026
ADME 0.65% 3,294 $ 1.892M Jul 31, 2026
BIGY 0.62% 251 $ 173.524K Nov 17, 2026
TFPN 0.60% 1,326 $ 916.704K Nov 17, 2026
SPIN 0.59% 381 $ 263.397K Nov 16, 2026
XMAG 0.59% 1,828 $ 1.279M Nov 13, 2026
TIME 0.59% 125 $ 86.416K Nov 17, 2026
HELO 0.58% 40,524 $ 27.831M Nov 17, 2026
FFLV 0.58% 165 $ 94.76K Jul 31, 2026
MODL 0.54% 11,122 $ 5.576M Jun 30, 2026
CGBL 0.52% 60,149 $ 41.583M Nov 16, 2026
GPT 0.51% 239 $ 119.825K Jun 30, 2026
THRO 0.51% 77,129 $ 53.322M Nov 16, 2026
JGLO 0.51% 42,726 $ 29.344M Nov 17, 2026
NBCR 0.49% 6,807 $ 4.201M Aug 31, 2026
JGRO 0.49% 64,219 $ 44.105M Nov 17, 2026
LDRX 0.47% 1,939 $ 1.197M Aug 31, 2026
PHEQ 0.47% 1,303 $ 653.272K Jun 30, 2026
CVAR 0.46% 345 $ 198.134K Jul 31, 2026
INRO 0.46% 3,898 $ 2.695M Nov 16, 2026
JUSA 0.45% 5,778 $ 3.968M Nov 17, 2026
LOWV 0.45% 1,475 $ 910.223K Aug 31, 2026
DAK 0.44% 269 $ 180K Nov 18, 2026
MSLC 0.44% 28,754 $ 17.744M Aug 31, 2026
LCTU 0.43% 7,077 $ 4.893M Nov 16, 2026
ACVF 0.40% 1,049 $ 602.441K Jul 31, 2026
GEW 0.39% 915 $ 564.647K Aug 31, 2026
LVDS 0.39% 673 $ 462.21K Nov 17, 2026
FELV 0.39% 24,602 $ 12.334M Jun 30, 2026
PEPS 0.38% 219 $ 109.798K Jun 30, 2026
AAUS 0.38% 2,803 $ 1.93M Nov 18, 2026